Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Margaret W Colton

2PUBLICATIONS
13CO-AUTHORS
Molecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Feb 19, 2025
Tumour-wide RNA splicing aberrations generate actionable public neoantigens.

Darwin W Kwok, Nicholas O Stevers, Iñaki Etxeberria

|Mar 04, 2021
OTS167 blocks FLT3 translation and synergizes with FLT3 inhibitors in FLT3 mutant acute myeloid leukemia.

Bartholomew J Eisfelder, Caner Saygin, Joseph Wynne

Pageof 1

Frequent Collaborators

1 joint publications

Nicholas O Stevers

1 joint publications

Iñaki Etxeberria

1 joint publications

Takahide Nejo

1 joint publications

Hirokazu Ogino

1 joint publications

Atsuro Saijo

1 joint publications

Aaron Diaz

1 joint publications

Joanna J Phillips

1 joint publications

Arun P Wiita

1 joint publications

Christopher A Klebanoff

1 joint publications

Joseph F Costello

Frequent Collaborators

1 joint publications

Nicholas O Stevers

1 joint publications

Iñaki Etxeberria

1 joint publications

Takahide Nejo

1 joint publications

Hirokazu Ogino

Top Related Videos

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in <em>In Vitro</em> Cancer Models
09:58

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in <em>In Vitro</em> Cancer Models

Published on : Dec 09, 2016

13.6K
Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors
04:36

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors

Published on : Oct 17, 2025

524
See more related videos

Top Related Videos

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in <em>In Vitro</em> Cancer Models
09:58

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in <em>In Vitro</em> Cancer Models

Published on : Dec 09, 2016

13.6K
Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors
04:36

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors

Published on : Oct 17, 2025

524
See more related videos